Discover
ETON
Eton Pharmaceuticals, Inc.
36.63
2 x 25.99
2 x 46.37
bid
ask
+
0.43
1.19%
2 @ 04:00 PM
36.19 -0.44 (1.20%)
| Ytd | 116.62% | |
| 1y | 161.46% |
35.95
day range
36.93
13.76
52 week range
37.50
| Open | 36.23 | Prev Close | 36.20 | Low | 35.95 | High | 36.93 | Mkt Cap | 1.00B |
| Vol | 450.38K | Avg Vol | 411.51K | EPS | -0.06 | P/E | N/A | Forward P/E | 19.54 |
| Beta | 0.89 | Short Ratio | 3.53 | Inst. Own | 65.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 30.39 | 200-d Avg | 21.41 | 1yr Est | 45.67 |
| Income Statement | |||
| Total Revenue | 24.27M | ||
| Revenues (USD) | 24.27M | ||
| Cost of Revenue | 9.53M | ||
| Gross Profit | 14.74M | ||
| Operating Expenses | 12.32M | ||
| Research and Development Expense | 1.88M | ||
| Selling, General and Administrative Expense | 10.45M | ||
| Operating Income | 2.41M | ||
| Interest Expense | 840.00K | ||
| Income Tax Expense | 20.00K | ||
| Net Income | 1.55M | ||
| Net Income Common Stock | 1.55M | ||
| Net Income Common Stock (USD) | 1.55M | ||
| Consolidated Income | 1.55M | ||
| Earnings per Basic Share | 0.06 | ||
| Earnings per Basic Share (USD) | 0.06 | ||
| Earnings per Diluted Share | 0.05 | ||
| Earning Before Interest & Taxes (EBIT) | 2.41M | ||
| Earning Before Interest & Taxes (USD) | 2.41M | ||
| Weighted Average Shares | 27.29M | ||
| Weighted Average Shares Diluted | 31.55M | ||
| Balance Sheet | |||
| Cash and Equivalents | 19.66M | ||
| Cash and Equivalents (USD) | 19.66M | ||
| Trade and Non-Trade Receivables | 13.41M | ||
| Current Assets | 53.25M | ||
| Property, Plant & Equipment Net | 673.00K | ||
| Total Assets | 97.71M | ||
| Debt Current | 11.81M | ||
| Total Debt | 31.19M | ||
| Current Liabilities | 44.18M | ||
| Debt Non-Current | 19.38M | ||
| Total Liabilities | 67.10M | ||
| Accumulated Retained Earnings (Deficit) | -110.94M | ||
| Shareholders Equity | 30.62M | ||
| Shareholders Equity (USD) | 30.62M | ||
| Assets Non-Current | 44.47M | ||
| Total Debt (USD) | 31.19M | ||
| Goodwill and Intangible Assets | 43.74M | ||
| Inventory | 14.47M | ||
| Liabilities Non-Current | 22.92M | ||
| Trade and Non-Trade Payables | 13.49M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.14M | ||
| Net Cash Flow from Financing | 1.39M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.28M | ||
| Capital Expenditure | -75.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -15.00M | ||
| Issuance (Purchase) of Equity Shares | 1.39M | ||
| Net Cash Flow from Investing | -15.07M | ||
| Net Cash Flow from Operations | 7.41M | ||
| Share Based Compensation | 1.52M | ||